In the ongoing effort to find stories with the words “Iranian” and “nuclear” in them and spin them into some insidious plot, officials are now pressing Russia for “more details” following the claim that Russian authorities prevented a shipment of radioactive material into Iran.
The shipment, which contained a quantity of Sodium-22 (22Na), was stopped by Russian customs officials for some unknown reason. Though initially reported as something that could “only be created in a nuclear reactor officials later corrected this to confirm that it was not only not exclusive to reactors but not commonly created within them, and instead is mostly created in particle accelerators and research reactors in university and medical environments.
Indeed, while the Associated Press was reporting it was “not immediately clear if the substance could be any use to Iran’s controversial nuclear program,” the reality is no, it would not be. 22Na is produced for two primary reasons, calibrating radiation testers and, much more importantly, as a medical isotope.
Of course it has been well established that Iran has been extremely low on fuel for its US-built Tehran Research Reactor, which produces materially all of the nation’s medical isotopes, and while Western officials have been putting the screws to them on acquiring more fuel for it, it isn’t hard to guess why Iranians would be trying to import the isotopes. Cancer, after all, continues even when sanctions are in place, and it isn’t surprising that Iran wasn’t content to abandon nuclear medicine. The real question is why Russia had such a problem with the export of a quantity of the isotope.
Last 5 posts by Jason Ditz
- Gaza Ceasefire Largely Holding After Weekend Flareup - July 15th, 2018
- US Officials Say Trainer Policies May Change After Afghan Insider Attack - July 15th, 2018
- Israel Attacks Airbase Outside Northern Syrian City of Aleppo - July 15th, 2018
- Trump Lowers Expectations for Russia Summit - July 15th, 2018
- Afghan Civilian Deaths Hit Record High, Says UN - July 15th, 2018